Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z-Reference-Cited by-同舟云学术

Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z

Published:2017-04-26 Issue:4 Volume:12 Page:e0174774
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Febo Marcelo,Blum Kenneth^ORCID,Badgaiyan Rajendra D.,Perez Pablo D.,Colon-Perez Luis M.,Thanos Panayotis K.,Ferris Craig F.,Kulkarni Praveen,Giordano John,Baron David,Gold Mark S.

Funder

National Institutes of Health (US)

National Institutes of Health

LifeExtension Foundation

The National Foundation for Holistic Addiction Studies

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference102 articles.

1. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings,2014

2. Medication-assisted therapies—tackling the opioid-overdose epidemic;ND Volkow;N Engl J Med,2014

3. Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trial;W Mei;Neuroscience,2010

4. Effect of the Novel Positive Allosteric Modulator of Metabotropic Glutamate Receptor 2 AZD8529 on Incubation of Methamphetamine Craving After Prolonged Voluntary Abstinence in a Rat Model;D Caprioli;Biol Psychiatry,2015

5. The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models;T Rubino;Biol Psychiatry,2015

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids;Journal of Personalized Medicine;2022-12-06

2. Offering a putative neurobiological “dopamine homeostatic” solution to overcome the perils of the reward deficiency syndrome pandemic: emergence of “precision behavioral management”;Annals of Translational Medicine;2022-12

3. Why haven't we solved the addiction crisis?;Journal of the Neurological Sciences;2022-11

4. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?;Journal of Personalized Medicine;2022-10-14

5. DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave® and Other Neurobiologically Based Modalities to Address Complexities of Chronic Pain in a Female Diagnosed with Reward Deficiency Syndrome (RDS): Emergence of Induction of “Dopamine Homeostasis” in the Face of the Opioid Crisis;Journal of Personalized Medicine;2022-08-30